期刊文献+

复方甘草酸单铵治疗玫瑰糠疹疗效观察

Effect of compound ammonium glycyrrhetatd injection on pityriasis rosea
原文传递
导出
摘要 目的探讨复方甘草酸单铵治疗玫瑰糠疹的疗效及其安全性。方法70例玫瑰糠疹患者分为2组,治疗组40例,给予复方甘草酸单铵注射液40ml,ivgtt,qd,;对照组30例,给予左西替力嗪5mg,qd,两组均外用炉甘石洗剂,每天2次;10d为一疗程。结果治疗组痊愈率及总有效率分别为72.5%和90.00%,对照组分别为53.33%和66.67%,两组比较均有显著性差异(P<0.01),两组均未见明显不良反应。结论复方甘草酸单铵治疗玫瑰糠疹疗效确切,疗程短,不良反应少,值得临床应用。 Objective To explore the effectiveness and safety of compound ammonium glycyrrhetatd injection for pityfiasis rosea. Methods 70 patients with pityfiasis rosea were divided into treatment group consisted of 40 cases treated with compound ammonium glycyrrhetatd injection 40mL, ivgtt, qd.and control group consisted of 30 cases treated with levocetirizine tablet, 5rag, qd. Meanwhile calamine lotion twice a day was externally used in the patients fo the two groups, for a course of 10 days. Results T he curerate and the total effective rate were 72.5% and 90.00% in the treatment group and 53.33% and 66.67% in the control group, showing significantly statistical differentce (P〈0.01). Conclusions The results show that compound ammonium glycyrrhctatd injection is effetivc on pityfiasis rosea without obvious adverse reactions.
出处 《中国热带医学》 CAS 2009年第6期1082-1082,1112,共2页 China Tropical Medicine
关键词 复方甘草酸单铵 玫瑰糠疹 Compound ammonium glycyrrhetatd injection Pityriasis rosea
  • 相关文献

参考文献2

二级参考文献19

  • 1凤幼茹,汪文成.强力宁治疗带状疱疹[J].中国医院药学杂志,1995,15(5):205-205. 被引量:10
  • 2[1]Takeda S,Ishthara K, Wakui Y, et al. Bioavailability study ofglycyrrhetic acid after oral administration of glycyrrhizin in rats;relevance to the intestinal bacterial hydrolysis[J].J PharmPharmacol,1996, 48(9):902.
  • 3[2]Van Rossum TG, Vulto AG, De Man RA, et al. Review article:glycyrrhizinas a potential treatment for chron-ic hepatitis C[J].Aliment Pharmacol Ther, 1998, 12(2):199.
  • 4[3]Van Rossum TG, Vulto AG, Hop WC, et al.Intraveno-us glycyrrhizin for the treatment of chronic hepatitis C:a double-blind, randomized, placebo controlled pha-se I/II trial[J]. J Gastroenterol Hepatol,1999, 14(11):1 093.
  • 5[4]Yamamura Y, Kotaki H, Tanaka N, et al. The pharmaco-kinetics of glycyrrhizin and its restorative effect on he-patic function in patients with chronic hepatitis and in chronicallycarbon-tetrachloride-intoxicated rats[J].Biopharm Drug Dispos, 1997, 18(8):717.
  • 6[5]Yamamura Y, Santa T, Kotaki H, et al. Administrationroute dependency of absorption of glycyrrhizin in rat-
  • 7[6]s:intraperitoneal administration dramatically enhancedbioavailability[J]. Biol Pharm Bull, 1995,18(2):337.
  • 8[7]Okamoto T, Tanaka N, Vulto AG, et al. The protectiveeffect of glycyrrhizin on anti-fas antibody-inducedhepatitis in mice[J]. Eur J Pharmacol, 2000, 387(2):229.
  • 9[8]Okamoto T, Kanda T, Vulto AG, et al. Glycyrrhizin protects mice fromconcanavalin A-induced hepatitiswithout affecting cytokine expression[J]. Int J Mol M-ecl, 1999, 4(2):149.
  • 10[9]Tsabota A. Corrbinecl ursodeoxycholic acid and glycyrrhizin therapy forchronic hepatitis C virus infection:a randomized controlled trial in 170patients[J].Eur J Gastroenterd Hepatol, 1999, 11(10):1 077.

共引文献108

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部